CVE-2024-8366
Published: 31 August 2024
Summary
CVE-2024-8366 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Code-Projects Pharmacy Management System. Its CVSS base score is 6.9 (Medium).
Operationally, ranked at the 28.1th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-49124
Vulnerability details
A vulnerability was found in code-projects Pharmacy Management System 1.0. It has been classified as problematic. This affects an unknown part of the file /index.php?id=userProfileEdit of the component Update My Profile Page. The manipulation of the argument fname/lname/email with the…
more
input <script>alert(1)</script> leads to cross site scripting. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.